Zain Rizvi is an expert on pharmaceutical innovation and access to medicines. He has provided technical assistance to state and national governments, coordinated civil society coalitions, and published on intellectual property, access to medicines and global health. He was a Gruber Fellow at SECTION27, a Johannesburg-based public interest organization. Zain obtained a J.D. from Yale Law School, where he was student director of the Yale Global Health Justice Partnership. He has a bachelor’s degree from McMaster University and has published in medical and legal journals, including The Lancet and the Yale Journal of Law & Technology.
Zain has been quoted or published in The New York Times, The Washington Post, The Wall Street Journal, The Financial Times, The Associated Press, The Intercept and The Nation.